5-alpha reductase inhibitors use in prostatic disease and beyond (2023)
Bodie Chislett, David Chen, Marlon L. Perera, Eric Chung, Damien Bolton, Liang G. Qu
Abstract
5-alpha reductase inhibitors (5-ARIs) are commonly used and widely available, with benefits observed from their effect on...